EagleClaw Capital Managment, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
EagleClaw Capital Managment, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,375,783
+4.3%
23,324
+3.3%
0.54%
+2.9%
Q2 2023$2,277,942
+6.2%
22,574
-3.2%
0.52%
+3.6%
Q1 2023$2,145,808
-2.7%
23,324
-4.1%
0.51%
-5.1%
Q4 2022$2,206,129
+18.4%
24,318
-0.8%
0.53%
+2.3%
Q3 2022$1,864,000
-11.4%
24,518
-1.5%
0.52%
-8.8%
Q2 2022$2,104,000
-3.4%
24,893
+0.3%
0.57%
+14.2%
Q1 2022$2,177,000
-0.3%
24,810
-0.6%
0.50%
+4.6%
Q4 2021$2,183,000
+8.9%
24,960
+1.6%
0.48%
-7.5%
Q3 2021$2,005,000
-8.1%
24,560
+2.7%
0.52%
-8.3%
Q2 2021$2,182,000
+16.2%
23,910
+8.8%
0.56%
+4.6%
Q1 2021$1,877,000
-9.7%
21,9850.0%0.54%
-18.5%
Q4 2020$2,079,000
+8.7%
21,9850.0%0.66%
-1.3%
Q3 2020$1,912,000
+3.7%
21,985
+4.1%
0.67%
-6.4%
Q2 2020$1,843,000
+1.5%
21,110
-4.3%
0.72%
-16.5%
Q1 2020$1,815,000
-13.2%
22,060
-0.2%
0.86%
+12.0%
Q4 2019$2,092,000
+9.0%
22,1150.0%0.76%
-2.2%
Q3 2019$1,919,000
-3.2%
22,115
+1.8%
0.78%
-9.4%
Q2 2019$1,983,000
-5.0%
21,7150.0%0.86%
-9.4%
Q1 2019$2,087,000
+14.8%
21,715
+2.4%
0.95%0.0%
Q4 2018$1,818,000
-0.5%
21,2150.0%0.95%
+19.1%
Q3 2018$1,828,000
+16.1%
21,215
+1.9%
0.80%
+4.7%
Q2 2018$1,574,000
-5.4%
20,815
+1.1%
0.76%
-9.3%
Q1 2018$1,664,000
-0.2%
20,596
+3.5%
0.84%0.0%
Q4 2017$1,668,000
+10.0%
19,896
+12.8%
0.84%
-1.9%
Q3 2017$1,517,000
-0.5%
17,646
-3.3%
0.86%
-4.0%
Q2 2017$1,525,000
+12.3%
18,2460.0%0.89%
+9.3%
Q1 2017$1,358,000
+1.0%
18,246
-1.1%
0.82%
-3.4%
Q4 2016$1,344,000
-7.6%
18,4460.0%0.85%
-8.8%
Q3 2016$1,454,000
-4.0%
18,446
+0.7%
0.93%
-7.8%
Q2 2016$1,515,000
+14.7%
18,3210.0%1.01%
+12.5%
Q1 2016$1,321,000
-17.2%
18,321
-1.1%
0.90%
-15.4%
Q4 2015$1,596,000
-7.4%
18,529
-1.1%
1.06%
-12.6%
Q3 2015$1,723,000
-8.4%
18,729
-1.9%
1.21%
+0.7%
Q2 2015$1,880,000
-0.9%
19,099
-0.8%
1.20%
-2.0%
Q1 2015$1,898,000
+5.7%
19,249
-0.5%
1.23%
+3.8%
Q4 2014$1,795,000
-1.8%
19,349
-0.5%
1.18%
-4.5%
Q3 2014$1,828,000
+4.8%
19,449
+0.6%
1.24%
+4.7%
Q2 2014$1,745,000
+8.5%
19,324
+2.5%
1.18%
+2.0%
Q1 2014$1,608,00018,8491.16%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders